Keyphrases
Multiple Sclerosis
100%
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
16%
COVID-19
16%
Vaccination
13%
Expanded Disability Status Scale
12%
Neuromyelitis Optica
10%
Central Vein Sign
10%
Acute Disseminated Encephalomyelitis
10%
Aquaporin-4 (AQP4)
10%
Multiple Sclerosis Diagnosis
10%
Disability
10%
McDonald Criteria
10%
Chronic Inflammatory Diseases
9%
Binocular
8%
Low-contrast Letter Acuity
8%
Immunosuppressive Therapy
7%
Disease-modifying Therapy
7%
Multiple Sclerosis Functional Composite
6%
Neurologist
6%
United States
6%
Tumour Necrosis Factor Inhibitor (TNFi)
6%
Multiple Sclerosis Treatment
6%
Clinical Care
5%
Knowledge Gaps
5%
Delta Virus
5%
Quantitative MRI
5%
Disability Accumulation
5%
Non-lesional
5%
Improved Outcomes
5%
Obesity
5%
Lesional
5%
Therapy Adherence
5%
Early multiple Sclerosis
5%
Brain Aging
5%
Gut Microbiota
5%
Quality of Life
5%
Progressive multifocal Leukoencephalopathy
5%
Specialty Drugs
5%
T Lymphocyte Function
5%
Immunosuppression
5%
Clinical Tool
5%
Phase II Trial
5%
Natalizumab
5%
Misapplication
5%
MRNA Vaccine
5%
Educational Intervention
5%
Prospective Cohort Study
5%
Singapore
5%
Diagnostic Biomarker
5%
Reduced Antibodies
5%
Medicine and Dentistry
Multiple Sclerosis
43%
Acute Disseminated Encephalomyelitis
10%
McDonald Criteria
10%
Pediatrics
8%
Diseases
7%
Neurology
5%
Central Vein
5%
Diagnosis
5%
Patient Care
5%
Magnetization Transfer
5%
Patient Compliance
5%
Medicare
5%
COVID-19 Vaccine
5%
Biological Marker
5%
Disease Modifying Therapy
5%
T Lymphocyte
5%
Symbol Digit Modalities Test
5%
Gut Microbiota
5%
B Lymphocyte
5%
Fumaric Acid Dimethyl Ester
5%
Lymphocyte Function
5%
Lymphocyte
5%
Magnetic Resonance Imaging
5%
